Skip to main content
Top
Published in: Osteoporosis International 5/2013

01-05-2013 | Original Article

Mortality and incident vertebral fractures after 3 years of follow-up among geriatric patients

Authors: H. C. van der Jagt-Willems, M. Vis, C. R. Tulner, J. P. C. M. van Campen, A. D. Woolf, B. C. van Munster, W. F. Lems

Published in: Osteoporosis International | Issue 5/2013

Login to get access

Abstract

Summary

In a prospective cohort study of 395 geriatric outpatients, mortality after 3 years was associated with prevalent vertebral fractures at baseline. The mortality risk was independently associated with the presence of three or more vertebral fractures at baseline. In the surviving patients, the risk of incident fractures was noteworthy, occurring in 26 % of these patients.

Introduction

The purpose of this study is to determine mortality rate and the incidence of vertebral fractures in a geriatric outpatient group, during a 3-year follow-up period, in a teaching hospital in Amsterdam, The Netherlands.

Methods

This study includes a prospective cohort study of 395 geriatric patients who had their baseline visit at a diagnostic day hospital in 2007 and 2008. They were invited for follow-up 3 years later. Lateral X-rays of the lumbar spine and chest were performed at baseline and after 3 years; vertebral fractures were scored in all patients according to the semi-quantitative method of Genant.

Results

After 3 years, mortality was 46 % and associated with prevalent vertebral fractures at baseline (odds ratio (OR), 1.83; 95 % CI, 1.23–2.74). The presence of three or more vertebral fractures at baseline was an independent risk factor for mortality (OR, 3.32; 95 % CI, 1.56–7.07). Other independently associated risk factors were greater age, higher co-morbidity score, and having more prescriptions. Higher cognitive capacity protected against mortality after 3 years. In 72 patients, radiography was repeated. Nineteen patients (26 %) had an incident radiographic vertebral fracture: 16 in those with a prevalent fracture, and 3 in those without a prevalent vertebral fracture at baseline.

Conclusions

In geriatric outpatients, mortality after 3 years was associated with prevalent vertebral fractures at baseline, and the mortality risk was independently associated with 3 or more vertebral fractures at baseline. In survivors, the risk of incident fractures was noteworthy, since these occurred in 26 % of the patients, particularly in those with a prevalent vertebral fracture.
Literature
1.
go back to reference Melton LJ 3rd, Atkinson EJ, Cooper C, O’Fallon WM, Riggs BL (1999) Vertebral fractures predict subsequent fractures. Osteoporosis Int 10:214–221CrossRef Melton LJ 3rd, Atkinson EJ, Cooper C, O’Fallon WM, Riggs BL (1999) Vertebral fractures predict subsequent fractures. Osteoporosis Int 10:214–221CrossRef
2.
go back to reference Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB et al (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285:320–323PubMedCrossRef Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB et al (2001) Risk of new vertebral fracture in the year following a fracture. JAMA 285:320–323PubMedCrossRef
3.
go back to reference der Jagt-Willems V, van Hengel M, Vis M et al (2012) Why do geriatric patients have so many vertebral fractures? Exploring prevalence and riskfactors. Age Ageing 41:200–206PubMedCrossRef der Jagt-Willems V, van Hengel M, Vis M et al (2012) Why do geriatric patients have so many vertebral fractures? Exploring prevalence and riskfactors. Age Ageing 41:200–206PubMedCrossRef
4.
go back to reference Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC et al (1996) Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535–1541PubMedCrossRef Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC et al (1996) Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348:1535–1541PubMedCrossRef
5.
go back to reference Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C et al (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: result from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 282:637–645PubMedCrossRef Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C et al (1999) Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: result from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 282:637–645PubMedCrossRef
6.
go back to reference Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML et al (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral efficacy with Risedronate Therapy (VERT) Study Group. Osteoporosis Int 11:83–91CrossRef Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML et al (2000) Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral efficacy with Risedronate Therapy (VERT) Study Group. Osteoporosis Int 11:83–91CrossRef
7.
go back to reference Reginster JY, Seeman E, De Vernejoul MC, Adami S, Compston J, Phenekos C et al (2005) Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Periferal Osteoporosis (TROPOS) Study. J Clin Endocrinol Metab 90:2816–2822PubMedCrossRef Reginster JY, Seeman E, De Vernejoul MC, Adami S, Compston J, Phenekos C et al (2005) Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Periferal Osteoporosis (TROPOS) Study. J Clin Endocrinol Metab 90:2816–2822PubMedCrossRef
9.
go back to reference Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761–1767PubMedCrossRef Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761–1767PubMedCrossRef
10.
go back to reference Kado DM, Browner WS, Palermo L, Nevitt MC, Genant HK, Cummings SR (1999) Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med 159:1215–1220PubMedCrossRef Kado DM, Browner WS, Palermo L, Nevitt MC, Genant HK, Cummings SR (1999) Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med 159:1215–1220PubMedCrossRef
11.
go back to reference Trone DW, Kritz-Silverstein D, Von Muhlen DG, Wingard DL, Barrett-Connor E (2007) Is radiographic vertebral fracture a risk factor for mortality? Am J Epidemiol 166:1191–1197PubMedCrossRef Trone DW, Kritz-Silverstein D, Von Muhlen DG, Wingard DL, Barrett-Connor E (2007) Is radiographic vertebral fracture a risk factor for mortality? Am J Epidemiol 166:1191–1197PubMedCrossRef
12.
go back to reference Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301:513–521PubMedCrossRef Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301:513–521PubMedCrossRef
13.
go back to reference Charlson ME, Pompei P, Ales K, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40:373–383PubMedCrossRef Charlson ME, Pompei P, Ales K, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis 40:373–383PubMedCrossRef
14.
go back to reference De Groot V, Beckerman H, Lankhorst GJ, Bouter LM (2003) How to measure comorbidity. A critical review of available methods. J Clin Epidemiol 56:221–229PubMedCrossRef De Groot V, Beckerman H, Lankhorst GJ, Bouter LM (2003) How to measure comorbidity. A critical review of available methods. J Clin Epidemiol 56:221–229PubMedCrossRef
15.
go back to reference Podsiadlo D, Richardson S (1991) The timed up and go: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39:142–148PubMed Podsiadlo D, Richardson S (1991) The timed up and go: a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39:142–148PubMed
16.
go back to reference Shumway-Cook A, Brauer S, Woollacott M (2000) Predicting the probabillity for falls in community-dwelling older adults using the timed up & go test. Phys Ther 80:896–903PubMed Shumway-Cook A, Brauer S, Woollacott M (2000) Predicting the probabillity for falls in community-dwelling older adults using the timed up & go test. Phys Ther 80:896–903PubMed
17.
go back to reference Folstein MF, Robins LN, Helzer JE (1983) The mini-mental state examination. Arch Gen Psychiatry 40:812PubMedCrossRef Folstein MF, Robins LN, Helzer JE (1983) The mini-mental state examination. Arch Gen Psychiatry 40:812PubMedCrossRef
18.
go back to reference Lips P, Cooper C, Agnusdei D, Caulin F, Egger P, Johnell O et al (1999) Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis. Osteoporosis Int 10:150–160CrossRef Lips P, Cooper C, Agnusdei D, Caulin F, Egger P, Johnell O et al (1999) Quality of life in patients with vertebral fractures: validation of the Quality of Life Questionnaire of the European Foundation for Osteoporosis (QUALEFFO). Working Party for Quality of Life of the European Foundation for Osteoporosis. Osteoporosis Int 10:150–160CrossRef
19.
go back to reference van Marwijk HWJ, Wallace P, De Bock GH, Hernans JO, Kaptein AA, Mulder JD (1995) Evaluation of the feasibility, reliability and diagnostic value of shortened versions of the geriatric depression scale. Br J Gen Pract 45:195–199PubMed van Marwijk HWJ, Wallace P, De Bock GH, Hernans JO, Kaptein AA, Mulder JD (1995) Evaluation of the feasibility, reliability and diagnostic value of shortened versions of the geriatric depression scale. Br J Gen Pract 45:195–199PubMed
20.
go back to reference Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M46–M56CrossRef Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J et al (2001) Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 56:M46–M56CrossRef
21.
go back to reference Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148PubMedCrossRef Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148PubMedCrossRef
22.
go back to reference Black DM, Palermo L, Nevitt MC et al (1995) Comparison of methods for defining prevalent vertebral deformities: the study of osteoporotic fractures. J Bone Miner Res 10:890–902PubMedCrossRef Black DM, Palermo L, Nevitt MC et al (1995) Comparison of methods for defining prevalent vertebral deformities: the study of osteoporotic fractures. J Bone Miner Res 10:890–902PubMedCrossRef
23.
go back to reference Grados F, Roux C, de Vernejoul MC, Utard G, Sebert JL, Fardellone P (2001) Comparison of four morphometric definitions and a semiquantitative consensus reading for assessing prevalent vertebral fractures. Osteoporos Int 12:716–722PubMedCrossRef Grados F, Roux C, de Vernejoul MC, Utard G, Sebert JL, Fardellone P (2001) Comparison of four morphometric definitions and a semiquantitative consensus reading for assessing prevalent vertebral fractures. Osteoporos Int 12:716–722PubMedCrossRef
25.
go back to reference Cauley JA, Thompson DE, Ensrud KC, Scott JC, Black D (2000) Risk of mortality following clinical fractures. Osteoporos Int 11:556–561PubMedCrossRef Cauley JA, Thompson DE, Ensrud KC, Scott JC, Black D (2000) Risk of mortality following clinical fractures. Osteoporos Int 11:556–561PubMedCrossRef
26.
go back to reference Pongchaiyakul C, Nguyen ND, Jones G, Center JR, Eisman JA, Nguyen TV (2005) Asymptomatic vertebral deformity as a major risk factor for subsequent fractures and mortality: a long-term prospective study. J Bone Miner Res 20:1349–1355PubMedCrossRef Pongchaiyakul C, Nguyen ND, Jones G, Center JR, Eisman JA, Nguyen TV (2005) Asymptomatic vertebral deformity as a major risk factor for subsequent fractures and mortality: a long-term prospective study. J Bone Miner Res 20:1349–1355PubMedCrossRef
27.
go back to reference Tosteson AN, Gottlieb DJ, Radley DC, Fisher ES, Melton LJ 3rd (2007) Excess mortality following hip fracture: the role of underlying health status. Osteoporos Int 18:1463–1472PubMedCrossRef Tosteson AN, Gottlieb DJ, Radley DC, Fisher ES, Melton LJ 3rd (2007) Excess mortality following hip fracture: the role of underlying health status. Osteoporos Int 18:1463–1472PubMedCrossRef
28.
go back to reference Browner WS, Seeley DG, Vogt TM, Cummings SR (1991) Study of osteoporotic fractures research group. Non-trauma mortality in elderly women with low bone mineral density. Lancet 338:355–358PubMedCrossRef Browner WS, Seeley DG, Vogt TM, Cummings SR (1991) Study of osteoporotic fractures research group. Non-trauma mortality in elderly women with low bone mineral density. Lancet 338:355–358PubMedCrossRef
29.
go back to reference Kado DM, Duong T, Stone KL et al (2003) Incident vertebral fractures and mortality in older women: a prospective study. Osteoporos Int 14:589–594PubMedCrossRef Kado DM, Duong T, Stone KL et al (2003) Incident vertebral fractures and mortality in older women: a prospective study. Osteoporos Int 14:589–594PubMedCrossRef
30.
go back to reference Ensrud KE, Ewing SK, Taylor BC, Fink HA, Stone KL, Cauley JA et al (2007) Frailty and risk of falls, fracture and mortality in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med 62:744–751CrossRef Ensrud KE, Ewing SK, Taylor BC, Fink HA, Stone KL, Cauley JA et al (2007) Frailty and risk of falls, fracture and mortality in older women: the study of osteoporotic fractures. J Gerontol A Biol Sci Med 62:744–751CrossRef
31.
go back to reference Ismail AA, O’Neill TW, Cooper C, Finn JD, Bhalla AK, Cannata JB et al (1998) Mortality associated with vertebral deformity in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int 8:291–297PubMedCrossRef Ismail AA, O’Neill TW, Cooper C, Finn JD, Bhalla AK, Cannata JB et al (1998) Mortality associated with vertebral deformity in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int 8:291–297PubMedCrossRef
32.
go back to reference Ensrud KE, Thompson DE, Cauley JA et al (2000) Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group. J Am Geriatr Soc 48:241–249PubMed Ensrud KE, Thompson DE, Cauley JA et al (2000) Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group. J Am Geriatr Soc 48:241–249PubMed
33.
go back to reference Bruyere O, Roux C, Nicolet D et al (2012) Severity of incident vertebral fracture and future fracture risk: a 3 year prospective study. Abstract OC6 on ECCEO Bruyere O, Roux C, Nicolet D et al (2012) Severity of incident vertebral fracture and future fracture risk: a 3 year prospective study. Abstract OC6 on ECCEO
34.
go back to reference Posthuma WF, Westendorp RG, Vandenbroucke JP (1994) Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased? BMJ 308:1268–1269PubMedCrossRef Posthuma WF, Westendorp RG, Vandenbroucke JP (1994) Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased? BMJ 308:1268–1269PubMedCrossRef
35.
go back to reference Netelenbos JC, Geusens PP, Ypma G, Buijs SJ (2011) Adherence and profile of non-persistence in patients treated for osteoporosis—a large scale, longterm retrospective study in the Netherlands. Osteoporosis Int 22:1537–1546CrossRef Netelenbos JC, Geusens PP, Ypma G, Buijs SJ (2011) Adherence and profile of non-persistence in patients treated for osteoporosis—a large scale, longterm retrospective study in the Netherlands. Osteoporosis Int 22:1537–1546CrossRef
36.
go back to reference Inderjeeth CA, Foo AC, Lai MM, Glendenning P (2009) Efficacy and safety of pharmacological agents in managing osteoporosis in the old: review of the evidence. Bone 44:744–751PubMedCrossRef Inderjeeth CA, Foo AC, Lai MM, Glendenning P (2009) Efficacy and safety of pharmacological agents in managing osteoporosis in the old: review of the evidence. Bone 44:744–751PubMedCrossRef
Metadata
Title
Mortality and incident vertebral fractures after 3 years of follow-up among geriatric patients
Authors
H. C. van der Jagt-Willems
M. Vis
C. R. Tulner
J. P. C. M. van Campen
A. D. Woolf
B. C. van Munster
W. F. Lems
Publication date
01-05-2013
Publisher
Springer-Verlag
Published in
Osteoporosis International / Issue 5/2013
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-012-2147-y

Other articles of this Issue 5/2013

Osteoporosis International 5/2013 Go to the issue